Product NDC: | 65841-637 |
Proprietary Name: | Divalproex Sodium |
Non Proprietary Name: | Divalproex Sodium |
Active Ingredient(s): | 250 mg/1 & nbsp; Divalproex Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-637 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078239 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130701 |
Package NDC: | 65841-637-05 |
Package Description: | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65841-637-05) |
NDC Code | 65841-637-05 |
Proprietary Name | Divalproex Sodium |
Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65841-637-05) |
Product NDC | 65841-637 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Divalproex Sodium |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130701 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |